|1984 - Bliss GVS Pharma Limited was incorporated on 11th December, as public limited company and promoted by Mr Gautam Ashra. The company operates in two segments, health care products and pharma products.
2004 - Public shareholders of the company received an open offer by the Fedex Securities Ltd on behalf of Shri M G Wagle, Shri Gautam R Ashra & Shri Shibroor N Kamath.
2005 - Board of directors of the company had recommended the issue of bonus shares of 2 shares for every 5 shares.
2006 -Board of directors of the company on 9th May, 2006, had approved to takeover GVS Lab and to change the name of the company from 'Bliss Chemicals & Pharmaceuticals India Ltd' to 'Bliss GVS Pharma Ltd'.
- Gautam Ashra, promoter director of the company, on 18th December 2006, sold 104,200 equity shares of the company for average sale price of Rs. 52.02 at the exchange.
-Company has changed its name from Bliss Chemicals & Pharmaceuticals India Ltd. to Bliss GVS Pharma Ltd.
2007 - The board of the company had approved on 15th Jan 2007, to take over GVS Labs of S N Kamath for a consideration of Rs 160 million. The entire consideration will be paid by way of issue of 2,666,667 shares on a preferential basis to Kamath at a price of Rs 60 each (at a premium of Rs. 50 each). The takeover of GVS Lab was effective from Apr. 01, 2006.
- The company had received an order of Rs. 25.00 crores for supply of Anti malarial Drugs for African Countries on November 2007.
- The company set up its new manufacturing unit for tablets, dry syrup, oral suspension and suppository pessaries in the existing manufacturing facility at Palghar in Maharashtra.
2008 - Members at the extra ordinary general meeting of the company had approved split of shares of face Value of Rs 10 each into face value of Rs 1 each.
-The company had fixed 18th March 2008 as the record date for the split of the equity shares of the company. The equity shares of face value Rs. 10 each will be sub divided in to face value of Rs. 1 each.
-The Company has issued Bonus Shares in the Ratio of 3:5.
-Company has received an Award from Pharmexcil
-Company successfully completed its 25th year of operations.
-Company has signed a Joint Venture Agreement with Kuwait
-Mr. S N. Kamath, Promoter & Managing Director of the company has received a "National Award -2009 from Government of India in recognition outstanding performance Entrepreneurship under Medium Enterprises".
-Registered Office of the Company has been shifted from 6/29-A, Udit Mittal Industry, Andheri Kurla Road, Andheri - East, Mumbai - 400 059 to 102, Hyde Park, Sakivihar Road, Andheri - East, Mumbai - 400 072
-Bliss GVS Pharma Ltd recommended of 30% Dividend i.e. Rs. 0.30 per equity share
-Company has acquired 70% management stake in the Company M/s. Kremoint Pharma Private Limited
-Bliss GVS Pharma Ltd recommended a dividend of 40%.
-Bliss GVS receives recognition for its Research & Development Lab from the Department of Scientific & Industrial Research (DSIR), Government of India.
-Bliss GVS is named in Moneylife magazine's 'Wealth Creators 2004-2013' list, an annual study of companies that have created the maximum wealth for investors over the past 10 years.
-Bliss GVS Wins - Outstanding Exports Award.
-Bliss GVS Pharma wins Healthcare Services contract in Kenya
-Bliss GVS Pharma arm wins $111 mn contract from Kenyan firm.